Pre-order Enquiry
Request Free Sample
Global and China Hereditary Cancer Testing Market Size, Status and Forecast 2020-2026
SKU ID : QYR-16365545 | Publishing Date : 03-Sep-2020
Request Sample
Request Customization
Check DiscountsDetailed TOC of Global and China Hereditary Cancer Testing Market Size, Status and Forecast 2020-2026
1 Report Overview1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Hereditary Cancer Testing Market Size Growth Rate by Type: 2020 VS 2026
1.2.2 RNA Testing
1.2.3 DNA Testing
1.3 Market by Application
1.3.1 Global Hereditary Cancer Testing Market Share by Application: 2020 VS 2026
1.3.2 Breast Cancer
1.3.3 Gastrointestinal Cancer
1.3.4 Prostate Cancer
1.3.5 Respiratory/Lung Cancer
1.3.6 Other Cancers
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Hereditary Cancer Testing Market Perspective (2015-2026)
2.2 Global Hereditary Cancer Testing Growth Trends by Regions
2.2.1 Hereditary Cancer Testing Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Hereditary Cancer Testing Historic Market Share by Regions (2015-2020)
2.2.3 Hereditary Cancer Testing Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Hereditary Cancer Testing Players by Market Size
3.1.1 Global Top Hereditary Cancer Testing Players by Revenue (2015-2020)
3.1.2 Global Hereditary Cancer Testing Revenue Market Share by Players (2015-2020)
3.2 Global Hereditary Cancer Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Hereditary Cancer Testing Revenue
3.4 Global Hereditary Cancer Testing Market Concentration Ratio
3.4.1 Global Hereditary Cancer Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Hereditary Cancer Testing Revenue in 2019
3.5 Key Players Hereditary Cancer Testing Area Served
3.6 Key Players Hereditary Cancer Testing Product Solution and Service
3.7 Date of Enter into Hereditary Cancer Testing Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Hereditary Cancer Testing Breakdown Data by Type (2015-2026)
4.1 Global Hereditary Cancer Testing Historic Market Size by Type (2015-2020)
4.2 Global Hereditary Cancer Testing Forecasted Market Size by Type (2021-2026)
5 Hereditary Cancer Testing Breakdown Data by Application (2015-2026)
5.1 Global Hereditary Cancer Testing Historic Market Size by Application (2015-2020)
5.2 Global Hereditary Cancer Testing Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Hereditary Cancer Testing Market Size (2015-2026)
6.2 North America Hereditary Cancer Testing Market Size by Type (2015-2020)
6.3 North America Hereditary Cancer Testing Market Size by Application (2015-2020)
6.4 North America Hereditary Cancer Testing Market Size by Country (2015-2020)
6.4.1 United States
6.4.2 Canada
7 Europe
7.1 Europe Hereditary Cancer Testing Market Size (2015-2026)
7.2 Europe Hereditary Cancer Testing Market Size by Type (2015-2020)
7.3 Europe Hereditary Cancer Testing Market Size by Application (2015-2020)
7.4 Europe Hereditary Cancer Testing Market Size by Country (2015-2020)
7.4.1 Germany
7.4.2 France
7.4.3 U.K.
7.4.4 Italy
7.4.5 Russia
7.4.6 Nordic
7.4.7 Rest of Europe
8 China
8.1 China Hereditary Cancer Testing Market Size (2015-2026)
8.2 China Hereditary Cancer Testing Market Size by Type (2015-2020)
8.3 China Hereditary Cancer Testing Market Size by Application (2015-2020)
8.4 China Hereditary Cancer Testing Market Size by Region (2015-2020)
8.4.1 China
8.4.2 Japan
8.4.3 South Korea
8.4.4 Southeast Asia
8.4.5 India
8.4.6 Australia
8.4.7 Rest of Asia-Pacific
9 Japan
9.1 Japan Hereditary Cancer Testing Market Size (2015-2026)
9.2 Japan Hereditary Cancer Testing Market Size by Type (2015-2020)
9.3 Japan Hereditary Cancer Testing Market Size by Application (2015-2020)
9.4 Japan Hereditary Cancer Testing Market Size by Country (2015-2020)
9.4.1 Mexico
9.4.2 Brazil
10 Southeast Asia
10.1 Southeast Asia Hereditary Cancer Testing Market Size (2015-2026)
10.2 Southeast Asia Hereditary Cancer Testing Market Size by Type (2015-2020)
10.3 Southeast Asia Hereditary Cancer Testing Market Size by Application (2015-2020)
10.4 Southeast Asia Hereditary Cancer Testing Market Size by Country (2015-2020)
10.4.1 Turkey
10.4.2 Saudi Arabia
10.4.3 UAE
10.4.4 Rest of Middle East & Africa
11 Key Players Profiles
11.1 Ambry Genetics (Konica Minota)
11.1.1 Ambry Genetics (Konica Minota) Company Details
11.1.2 Ambry Genetics (Konica Minota) Business Overview
11.1.3 Ambry Genetics (Konica Minota) Hereditary Cancer Testing Introduction
11.1.4 Ambry Genetics (Konica Minota) Revenue in Hereditary Cancer Testing Business (2015-2020))
11.1.5 Ambry Genetics (Konica Minota) Recent Development
11.2 Asper Biogene
11.2.1 Asper Biogene Company Details
11.2.2 Asper Biogene Business Overview
11.2.3 Asper Biogene Hereditary Cancer Testing Introduction
11.2.4 Asper Biogene Revenue in Hereditary Cancer Testing Business (2015-2020)
11.2.5 Asper Biogene Recent Development
11.3 Natera
11.3.1 Natera Company Details
11.3.2 Natera Business Overview
11.3.3 Natera Hereditary Cancer Testing Introduction
11.3.4 Natera Revenue in Hereditary Cancer Testing Business (2015-2020)
11.3.5 Natera Recent Development
11.4 Caris Life Sciences
11.4.1 Caris Life Sciences Company Details
11.4.2 Caris Life Sciences Business Overview
11.4.3 Caris Life Sciences Hereditary Cancer Testing Introduction
11.4.4 Caris Life Sciences Revenue in Hereditary Cancer Testing Business (2015-2020)
11.4.5 Caris Life Sciences Recent Development
11.5 BioReference Laboratories (GeneDx)
11.5.1 BioReference Laboratories (GeneDx) Company Details
11.5.2 BioReference Laboratories (GeneDx) Business Overview
11.5.3 BioReference Laboratories (GeneDx) Hereditary Cancer Testing Introduction
11.5.4 BioReference Laboratories (GeneDx) Revenue in Hereditary Cancer Testing Business (2015-2020)
11.5.5 BioReference Laboratories (GeneDx) Recent Development
11.6 LabSolutions
11.6.1 LabSolutions Company Details
11.6.2 LabSolutions Business Overview
11.6.3 LabSolutions Hereditary Cancer Testing Introduction
11.6.4 LabSolutions Revenue in Hereditary Cancer Testing Business (2015-2020)
11.6.5 LabSolutions Recent Development
11.7 Progenity，Inc
11.7.1 Progenity，Inc Company Details
11.7.2 Progenity，Inc Business Overview
11.7.3 Progenity，Inc Hereditary Cancer Testing Introduction
11.7.4 Progenity，Inc Revenue in Hereditary Cancer Testing Business (2015-2020)
11.7.5 Progenity，Inc Recent Development
11.8 ARUP Laboratories
11.8.1 ARUP Laboratories Company Details
11.8.2 ARUP Laboratories Business Overview
11.8.3 ARUP Laboratories Hereditary Cancer Testing Introduction
11.8.4 ARUP Laboratories Revenue in Hereditary Cancer Testing Business (2015-2020)
11.8.5 ARUP Laboratories Recent Development
11.9 NeoGenomics
11.9.1 NeoGenomics Company Details
11.9.2 NeoGenomics Business Overview
11.9.3 NeoGenomics Hereditary Cancer Testing Introduction
11.9.4 NeoGenomics Revenue in Hereditary Cancer Testing Business (2015-2020)
11.9.5 NeoGenomics Recent Development
11.10 Blueprint Genetics
11.10.1 Blueprint Genetics Company Details
11.10.2 Blueprint Genetics Business Overview
11.10.3 Blueprint Genetics Hereditary Cancer Testing Introduction
11.10.4 Blueprint Genetics Revenue in Hereditary Cancer Testing Business (2015-2020)
11.10.5 Blueprint Genetics Recent Development
11.11 CellMax Life
10.11.1 CellMax Life Company Details
10.11.2 CellMax Life Business Overview
10.11.3 CellMax Life Hereditary Cancer Testing Introduction
10.11.4 CellMax Life Revenue in Hereditary Cancer Testing Business (2015-2020)
10.11.5 CellMax Life Recent Development
11.12 Fulgent Genetics
10.12.1 Fulgent Genetics Company Details
10.12.2 Fulgent Genetics Business Overview
10.12.3 Fulgent Genetics Hereditary Cancer Testing Introduction
10.12.4 Fulgent Genetics Revenue in Hereditary Cancer Testing Business (2015-2020)
10.12.5 Fulgent Genetics Recent Development
11.13 Myriad Genetics
10.13.1 Myriad Genetics Company Details
10.13.2 Myriad Genetics Business Overview
10.13.3 Myriad Genetics Hereditary Cancer Testing Introduction
10.13.4 Myriad Genetics Revenue in Hereditary Cancer Testing Business (2015-2020)
10.13.5 Myriad Genetics Recent Development
11.14 Myogenes
10.14.1 Myogenes Company Details
10.14.2 Myogenes Business Overview
10.14.3 Myogenes Hereditary Cancer Testing Introduction
10.14.4 Myogenes Revenue in Hereditary Cancer Testing Business (2015-2020)
10.14.5 Myogenes Recent Development
11.15 LabCorp
10.15.1 LabCorp Company Details
10.15.2 LabCorp Business Overview
10.15.3 LabCorp Hereditary Cancer Testing Introduction
10.15.4 LabCorp Revenue in Hereditary Cancer Testing Business (2015-2020)
10.15.5 LabCorp Recent Development
11.16 Quest Diagnostics
10.16.1 Quest Diagnostics Company Details
10.16.2 Quest Diagnostics Business Overview
10.16.3 Quest Diagnostics Hereditary Cancer Testing Introduction
10.16.4 Quest Diagnostics Revenue in Hereditary Cancer Testing Business (2015-2020)
10.16.5 Quest Diagnostics Recent Development
11.17 Pathway Genomics
10.17.1 Pathway Genomics Company Details
10.17.2 Pathway Genomics Business Overview
10.17.3 Pathway Genomics Hereditary Cancer Testing Introduction
10.17.4 Pathway Genomics Revenue in Hereditary Cancer Testing Business (2015-2020)
10.17.5 Pathway Genomics Recent Development
11.18 Strand Life Sciences
10.18.1 Strand Life Sciences Company Details
10.18.2 Strand Life Sciences Business Overview
10.18.3 Strand Life Sciences Hereditary Cancer Testing Introduction
10.18.4 Strand Life Sciences Revenue in Hereditary Cancer Testing Business (2015-2020)
10.18.5 Strand Life Sciences Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Figures, Tables and Charts Available in Global and China Hereditary Cancer Testing Market Size, Status and Forecast 2020-2026
List of TablesTable 1. Global Hereditary Cancer Testing Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 3. Key Players of RNA Testing
Table 4. Key Players of DNA Testing
Table 5. Global Hereditary Cancer Testing Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 6. Global Hereditary Cancer Testing Market Size by Regions (US$ Million): 2020 VS 2026
Table 7. Global Hereditary Cancer Testing Market Size by Regions (2015-2020) (US$ Million)
Table 8. Global Hereditary Cancer Testing Market Share by Regions (2015-2020)
Table 9. Global Hereditary Cancer Testing Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 10. Global Hereditary Cancer Testing Market Share by Regions (2021-2026)
Table 11. Hereditary Cancer Testing Market Market Trends
Table 12. Hereditary Cancer Testing Market Drivers
Table 13. Hereditary Cancer Testing Market Challenges
Table 14. Hereditary Cancer Testing Market Restraints
Table 15. Global Hereditary Cancer Testing Revenue by Players (2015-2020) (US$ Million)
Table 16. Global Hereditary Cancer Testing Market Share by Players (2015-2020)
Table 17. Global Top Hereditary Cancer Testing Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Hereditary Cancer Testing as of 2019)
Table 18. Global Hereditary Cancer Testing by Players Market Concentration Ratio (CR5 and HHI)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Hereditary Cancer Testing Product Solution and Service
Table 21. Mergers & Acquisitions, Expansion Plans
Table 22. Global Hereditary Cancer Testing Market Size by Type (2015-2020) (US$ Million)
Table 23. Global Hereditary Cancer Testing Market Size Share by Type (2015-2020)
Table 24. Global Hereditary Cancer Testing Revenue Market Share by Type (2021-2026)
Table 25. Global Hereditary Cancer Testing Market Size Share by Application (2015-2020)
Table 26. Global Hereditary Cancer Testing Market Size by Application (2015-2020) (US$ Million)
Table 27. Global Hereditary Cancer Testing Market Size Share by Application (2021-2026)
Table 28. North America Hereditary Cancer Testing Market Size by Type (2015-2020) (US$ Million)
Table 29. North America Hereditary Cancer Testing Market Share by Type (2015-2020)
Table 30. North America Hereditary Cancer Testing Market Size by Application (2015-2020) (US$ Million)
Table 31. North America Hereditary Cancer Testing Market Share by Application (2015-2020)
Table 32. North America Hereditary Cancer Testing Market Size by Country (US$ Million) (2015-2020)
Table 33. North America Hereditary Cancer Testing Market Share by Country (2015-2020)
Table 34. Europe Hereditary Cancer Testing Market Size by Type (2015-2020) (US$ Million)
Table 35. Europe Hereditary Cancer Testing Market Share by Type (2015-2020)
Table 36. Europe Hereditary Cancer Testing Market Size by Application (2015-2020) (US$ Million)
Table 37. Europe Hereditary Cancer Testing Market Share by Application (2015-2020)
Table 38. Europe Hereditary Cancer Testing Market Size by Country (US$ Million) (2015-2020)
Table 39. Europe Hereditary Cancer Testing Market Share by Country (2015-2020)
Table 40. China Hereditary Cancer Testing Market Size by Type (2015-2020) (US$ Million)
Table 41. China Hereditary Cancer Testing Market Share by Type (2015-2020)
Table 42. China Hereditary Cancer Testing Market Size by Application (2015-2020) (US$ Million)
Table 43. China Hereditary Cancer Testing Market Share by Application (2015-2020)
Table 44. China Hereditary Cancer Testing Market Size by Region (US$ Million) (2015-2020)
Table 45. China Hereditary Cancer Testing Market Share by Region (2015-2020)
Table 46. Japan Hereditary Cancer Testing Market Size by Type (2015-2020) (US$ Million)
Table 47. Japan Hereditary Cancer Testing Market Share by Type (2015-2020)
Table 48. Japan Hereditary Cancer Testing Market Size by Application (2015-2020) (US$ Million)
Table 49. Japan Hereditary Cancer Testing Market Share by Application (2015-2020)
Table 50. Japan Hereditary Cancer Testing Market Size by Country (US$ Million) (2015-2020)
Table 51. Japan Hereditary Cancer Testing Market Share by Country (2015-2020)
Table 52. Southeast Asia Hereditary Cancer Testing Market Size by Type (2015-2020) (US$ Million)
Table 53. Southeast Asia Hereditary Cancer Testing Market Share by Type (2015-2020)
Table 54. Southeast Asia Hereditary Cancer Testing Market Size by Application (2015-2020) (US$ Million)
Table 55. Southeast Asia Hereditary Cancer Testing Market Share by Application (2015-2020)
Table 56. Southeast Asia Hereditary Cancer Testing Market Size by Country (US$ Million) (2015-2020)
Table 57. Southeast Asia Hereditary Cancer Testing Market Share by Country (2015-2020)
Table 58. Ambry Genetics (Konica Minota) Company Details
Table 59. Ambry Genetics (Konica Minota) Business Overview
Table 60. Ambry Genetics (Konica Minota) Product
Table 61. Ambry Genetics (Konica Minota) Revenue in Hereditary Cancer Testing Business (2015-2020) (US$ Million)
Table 62. Ambry Genetics (Konica Minota) Recent Development
Table 63. Asper Biogene Company Details
Table 64. Asper Biogene Business Overview
Table 65. Asper Biogene Product
Table 66. Asper Biogene Revenue in Hereditary Cancer Testing Business (2015-2020) (US$ Million)
Table 67. Asper Biogene Recent Development
Table 68. Natera Company Details
Table 69. Natera Business Overview
Table 70. Natera Product
Table 71. Natera Revenue in Hereditary Cancer Testing Business (2015-2020) (US$ Million)
Table 72. Natera Recent Development
Table 73. Caris Life Sciences Company Details
Table 74. Caris Life Sciences Business Overview
Table 75. Caris Life Sciences Product
Table 76. Caris Life Sciences Revenue in Hereditary Cancer Testing Business (2015-2020) (US$ Million)
Table 77. Caris Life Sciences Recent Development
Table 78. BioReference Laboratories (GeneDx) Company Details
Table 79. BioReference Laboratories (GeneDx) Business Overview
Table 80. BioReference Laboratories (GeneDx) Product
Table 81. BioReference Laboratories (GeneDx) Revenue in Hereditary Cancer Testing Business (2015-2020) (US$ Million)
Table 82. BioReference Laboratories (GeneDx) Recent Development
Table 83. LabSolutions Company Details
Table 84. LabSolutions Business Overview
Table 85. LabSolutions Product
Table 86. LabSolutions Revenue in Hereditary Cancer Testing Business (2015-2020) (US$ Million)
Table 87. LabSolutions Recent Development
Table 88. Progenity，Inc Company Details
Table 89. Progenity，Inc Business Overview
Table 90. Progenity，Inc Product
Table 91. Progenity，Inc Revenue in Hereditary Cancer Testing Business (2015-2020) (US$ Million)
Table 92. Progenity，Inc Recent Development
Table 93. ARUP Laboratories Business Overview
Table 94. ARUP Laboratories Product
Table 95. ARUP Laboratories Company Details
Table 96. ARUP Laboratories Revenue in Hereditary Cancer Testing Business (2015-2020) (US$ Million)
Table 97. ARUP Laboratories Recent Development
Table 98. NeoGenomics Company Details
Table 99. NeoGenomics Business Overview
Table 100. NeoGenomics Product
Table 101. NeoGenomics Revenue in Hereditary Cancer Testing Business (2015-2020) (US$ Million)
Table 102. NeoGenomics Recent Development
Table 103. Blueprint Genetics Company Details
Table 104. Blueprint Genetics Business Overview
Table 105. Blueprint Genetics Product
Table 106. Blueprint Genetics Revenue in Hereditary Cancer Testing Business (2015-2020) (US$ Million)
Table 107. Blueprint Genetics Recent Development
Table 108. CellMax Life Company Details
Table 109. CellMax Life Business Overview
Table 110. CellMax Life Product
Table 111. CellMax Life Revenue in Hereditary Cancer Testing Business (2015-2020) (US$ Million)
Table 112. CellMax Life Recent Development
Table 113. Fulgent Genetics Company Details
Table 114. Fulgent Genetics Business Overview
Table 115. Fulgent Genetics Product
Table 116. Fulgent Genetics Revenue in Hereditary Cancer Testing Business (2015-2020) (US$ Million)
Table 117. Fulgent Genetics Recent Development
Table 118. Myriad Genetics Company Details
Table 119. Myriad Genetics Business Overview
Table 120. Myriad Genetics Product
Table 121. Myriad Genetics Revenue in Hereditary Cancer Testing Business (2015-2020) (US$ Million)
Table 122. Myriad Genetics Recent Development
Table 123. Myogenes Company Details
Table 124. Myogenes Business Overview
Table 125. Myogenes Product
Table 126. Myogenes Revenue in Hereditary Cancer Testing Business (2015-2020) (US$ Million)
Table 127. Myogenes Recent Development
Table 128. LabCorp Company Details
Table 129. LabCorp Business Overview
Table 130. LabCorp Product
Table 131. LabCorp Revenue in Hereditary Cancer Testing Business (2015-2020) (US$ Million)
Table 132. LabCorp Recent Development
Table 133. Quest Diagnostics Company Details
Table 134. Quest Diagnostics Business Overview
Table 135. Quest Diagnostics Product
Table 136. Quest Diagnostics Revenue in Hereditary Cancer Testing Business (2015-2020) (US$ Million)
Table 137. Quest Diagnostics Recent Development
Table 138. Pathway Genomics Company Details
Table 139. Pathway Genomics Business Overview
Table 140. Pathway Genomics Product
Table 141. Pathway Genomics Revenue in Hereditary Cancer Testing Business (2015-2020) (US$ Million)
Table 142. Pathway Genomics Recent Development
Table 143. Strand Life Sciences Company Details
Table 144. Strand Life Sciences Business Overview
Table 145. Strand Life Sciences Product
Table 146. Strand Life Sciences Revenue in Hereditary Cancer Testing Business (2015-2020) (US$ Million)
Table 147. Strand Life Sciences Recent Development
Table 148. Research Programs/Design for This Report
Table 149. Key Data Information from Secondary Sources
Table 150. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Hereditary Cancer Testing Market Share by Type: 2020 VS 2026
Figure 2. RNA Testing Features
Figure 3. DNA Testing Features
Figure 4. Global Hereditary Cancer Testing Market Share by Application: 2020 VS 2026
Figure 5. Breast Cancer Case Studies
Figure 6. Gastrointestinal Cancer Case Studies
Figure 7. Prostate Cancer Case Studies
Figure 8. Respiratory/Lung Cancer Case Studies
Figure 9. Other Cancers Case Studies
Figure 10. Hereditary Cancer Testing Report Years Considered
Figure 11. Global Hereditary Cancer Testing Market Size (US$ Million), YoY Growth 2015-2026
Figure 12. Global Hereditary Cancer Testing Market Share by Regions: 2020 VS 2026
Figure 13. Global Hereditary Cancer Testing Market Share by Regions (2021-2026)
Figure 14. Global Hereditary Cancer Testing Market Share by Players in 2019
Figure 15. Global Top Hereditary Cancer Testing Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Hereditary Cancer Testing as of 2019
Figure 16. The Top 10 and 5 Players Market Share by Hereditary Cancer Testing Revenue in 2019
Figure 17. North America Hereditary Cancer Testing Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 18. United States Hereditary Cancer Testing Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 19. Canada Hereditary Cancer Testing Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 20. Europe Hereditary Cancer Testing Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 21. Germany Hereditary Cancer Testing Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 22. France Hereditary Cancer Testing Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 23. U.K. Hereditary Cancer Testing Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 24. Italy Hereditary Cancer Testing Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 25. Russia Hereditary Cancer Testing Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 26. Nordic Hereditary Cancer Testing Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 27. Rest of Europe Hereditary Cancer Testing Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 28. Asia-Pacific Hereditary Cancer Testing Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 29. China Hereditary Cancer Testing Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 30. Japan Hereditary Cancer Testing Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 31. South Korea Hereditary Cancer Testing Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 32. Southeast Asia Hereditary Cancer Testing Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 33. India Hereditary Cancer Testing Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 34. Australia Hereditary Cancer Testing Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 35. Rest of Asia-Pacific Hereditary Cancer Testing Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 36. Latin America Hereditary Cancer Testing Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 37. Mexico Hereditary Cancer Testing Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 38. Brazil Hereditary Cancer Testing Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 39. Middle East & Africa Hereditary Cancer Testing Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 40. Turkey Hereditary Cancer Testing Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 41. Saudi Arabia Hereditary Cancer Testing Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 42. UAE Hereditary Cancer Testing Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 43. Rest of Middle East & Africa Hereditary Cancer Testing Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 44. Ambry Genetics (Konica Minota) Revenue Growth Rate in Hereditary Cancer Testing Business (2015-2020)
Figure 45. Asper Biogene Revenue Growth Rate in Hereditary Cancer Testing Business (2015-2020)
Figure 46. Natera Revenue Growth Rate in Hereditary Cancer Testing Business (2015-2020)
Figure 47. Caris Life Sciences Revenue Growth Rate in Hereditary Cancer Testing Business (2015-2020)
Figure 48. BioReference Laboratories (GeneDx) Revenue Growth Rate in Hereditary Cancer Testing Business (2015-2020)
Figure 49. LabSolutions Revenue Growth Rate in Hereditary Cancer Testing Business (2015-2020)
Figure 50. Progenity，Inc Revenue Growth Rate in Hereditary Cancer Testing Business (2015-2020)
Figure 51. ARUP Laboratories Revenue Growth Rate in Hereditary Cancer Testing Business (2015-2020)
Figure 52. NeoGenomics Revenue Growth Rate in Hereditary Cancer Testing Business (2015-2020)
Figure 53. Blueprint Genetics Revenue Growth Rate in Hereditary Cancer Testing Business (2015-2020)
Figure 54. CellMax Life Revenue Growth Rate in Hereditary Cancer Testing Business (2015-2020)
Figure 55. Fulgent Genetics Revenue Growth Rate in Hereditary Cancer Testing Business (2015-2020)
Figure 56. Myriad Genetics Revenue Growth Rate in Hereditary Cancer Testing Business (2015-2020)
Figure 57. Myogenes Revenue Growth Rate in Hereditary Cancer Testing Business (2015-2020)
Figure 58. LabCorp Revenue Growth Rate in Hereditary Cancer Testing Business (2015-2020)
Figure 59. Quest Diagnostics Revenue Growth Rate in Hereditary Cancer Testing Business (2015-2020)
Figure 60. Pathway Genomics Revenue Growth Rate in Hereditary Cancer Testing Business (2015-2020)
Figure 61. Strand Life Sciences Revenue Growth Rate in Hereditary Cancer Testing Business (2015-2020)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
Keyplayers in Global and China Hereditary Cancer Testing Market Size, Status and Forecast 2020-2026
Ambry Genetics (Konica Minota)Asper Biogene
Natera
Caris Life Sciences
BioReference Laboratories (GeneDx)
LabSolutions
Progenity，Inc
ARUP Laboratories
NeoGenomics
Blueprint Genetics
CellMax Life
Fulgent Genetics
Myriad Genetics
Myogenes
LabCorp
Quest Diagnostics
Pathway Genomics
Strand Life Sciences
